SSY Group Ltd

02005

Company Profile

  • Business description

    SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.

  • Contact

    Central Plaza, 18 Harbour Road
    Rooms 4902-03, 49th Floor
    Wanchai
    Hong Kong
    HKG

    T: +852 26880869

    http://www.ssygroup.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    5,500

Stocks News & Analysis

stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.
stocks

Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.
stocks

What did Morningstar subscribers buy and sell in April?

How the most traded shares in April stack up against our analysts views.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,870.6046.70-0.52%
CAC 407,952.55129.72-1.61%
DAX 4023,950.57505.69-2.07%
Dow JONES (US)49,526.17537.29-1.07%
FTSE 10010,195.37177.56-1.71%
HKSE25,962.73426.31-1.62%
NASDAQ26,225.14410.08-1.54%
Nikkei 22561,409.291,244.76-1.99%
NZX 50 Index12,965.0160.06-0.46%
S&P 5007,408.5092.74-1.24%
S&P/ASX 2008,630.8042.70-0.49%
SSE Composite Index4,135.3942.53-1.02%

Market Movers